The duck EB66® cell substrate reveals a novel retrotransposon

被引:1
|
作者
Perugi, Fabien [1 ]
Freslon-Evain, Caroline [1 ]
Batard, Luc [1 ]
Guillet, Pauline [1 ,2 ]
Schwamborn, Klaus [1 ]
机构
[1] Valneva SE, 6 Rue Alain Bombard, F-44800 St Herblain, France
[2] EFS Atlantic Bio GMP, 2 Rue Aronnax, F-44800 St Herblain, France
关键词
EB66 (R); Cell substrate; Vaccine; Reverse transcriptase activity; Non-LTR retrotransposon; Chicken repeat 1; REVERSE-TRANSCRIPTASE ACTIVITY; TELOMERASE; RETROVIRUSES; PURIFICATION; PARTICLES; PROTEINS; VESICLES; AGENTS; HIV-1; LINE;
D O I
10.1016/j.biologicals.2019.08.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
During the establishment of the duck EB66 (R) cell line as a new cell substrate for vaccine production in industry, a very low level of reverse transcriptase (RT) activity was detected in the culture supernatant by product-enhanced RT assay but a whole battery of tests failed to evidence infectious particles. Results from extensive biochemical and physical testing demonstrated that RT activity was associated to an intracellular, non-enveloped and dense structure different from an infectious retroviruses. In silico analysis of Anas platyrhynchos genome revealed that the most likely candidates for encoding a ribonucleoprotein (RNP)-associated RT were nine copies of chicken repeat 1 (CR1)-like elements, belonging to the non-long terminal repeat retrotransposons. The presence of the full length Anas platyrhynchos chicken repeat 1 like sequence (APCR1) was confirmed in EB66 (R) cells and the related ribonucleic acid was present in the RT-containing fraction of EB66 (R) cells.
引用
收藏
页码:22 / 31
页数:10
相关论文
共 50 条
  • [1] The EB66® cell line as a valuable cell substrate for MVA-based vaccines production
    Leon, Arnaud
    David, Anne-Laure
    Madeline, Brice
    Guianvarc'h, Laurence
    Dureau, Elodie
    Champion-Arnaud, Patrick
    Hebben, Matthias
    Huss, Thierry
    Chatrenet, Benoit
    Schwamborn, Klaus
    VACCINE, 2016, 34 (48) : 5878 - 5885
  • [2] EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity
    Olivier, Stephane
    Jacoby, Marine
    Brillon, Cedric
    Bouletreau, Sylvana
    Mollet, Thomas
    Nerriere, Olivier
    Angel, Audrey
    Danet, Severine
    Souttou, Boussad
    Guehenneux, Fabienne
    Gauthier, Laurent
    Berthome, Mathilde
    Vie, Henri
    Beltraminelli, Nicola
    Mehtali, Majid
    MABS, 2010, 2 (04) : 405 - 415
  • [3] Immunogenicity and protective efficacy of an EB66® cell culture-derived duck Tembusu virus vaccine
    Yang, Zhiyuan
    Wang, Jiaqi
    Wang, Xiuqing
    Duan, Huijuan
    He, Pingyou
    Yang, Guijun
    Liu, Lixin
    Cheng, Huimin
    Wang, Xiaolei
    Pan, Jie
    Zhao, Jicheng
    Yu, Hongwei
    Yang, Baoshou
    Liu, Yuehuan
    Lin, Jian
    AVIAN PATHOLOGY, 2020, 49 (05) : 448 - 456
  • [4] Optimization of Newcastle Disease Virus Production in the Avian EB66 Cell Line
    Stevens, Brenna A. Y.
    Santry, Lisa A.
    Yates, Jacob E. G.
    Barachuy, Enzo M.
    Major, Pierre P.
    Bridle, Byram W.
    Wootton, Sarah K.
    MOLECULAR THERAPY, 2021, 29 (04) : 322 - 322
  • [5] Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
    Alexander Nikolay
    Arnaud Léon
    Klaus Schwamborn
    Yvonne Genzel
    Udo Reichl
    Applied Microbiology and Biotechnology, 2018, 102 : 8725 - 8737
  • [6] Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
    Nikolay, Alexander
    Leon, Arnaud
    Schwamborn, Klaus
    Genzel, Yvonne
    Reichl, Udo
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2018, 102 (20) : 8725 - 8737
  • [7] Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation
    White, Kris M.
    Ayllon, Juan
    Mena, Ignacio
    Potenski, Anna
    Krammer, Florian
    Garcia-Sastre, Adolfo
    VACCINE, 2018, 36 (09) : 1146 - 1153
  • [8] A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03
    Naruse, Takeshi
    Fukuda, Tadashi
    Tanabe, Tetsuro
    Ichikawa, Munetaka
    Oda, Yoshiaki
    Tochihara, Shinji
    Kimachi, Kazuhiko
    Kino, Yoichiro
    Ueda, Kohji
    VACCINE, 2015, 33 (45) : 6078 - 6084
  • [9] Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform
    Endo, Masafumi
    Tanishima, Mitsuyoshi
    Ibaragi, Kayo
    Hayashida, Kenshi
    Fukuda, Tadashi
    Tanabe, Tetsuro
    Naruse, Takeshi
    Kino, Yoichiro
    Ueda, Kohji
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2020, 14 (05) : 551 - 563
  • [10] Novel retrotransposon analysis reveals multiple mobility pathways dictated by hosts
    Ichiyanagi, Kenji
    Nakajima, Ryo
    Kajikawa, Masaki
    Okada, Norihiro
    GENOME RESEARCH, 2007, 17 (01) : 33 - 41